Goldman Sachs Group Inc Ars Pharmaceuticals, Inc. Comm Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Goldman Sachs Group Inc holds 886,117 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
886,117
Previous 275,855
221.23%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions